Announces new targets, including Net-Zero greenhouse gas emissions (GHG) across Scope 1 and Scope 2 by 2050 and 100% renewable electricity by 2040
Introduces company’s refreshed sustainability strategy, goals and governance
Formerly called the Corporate Responsibility Report, now published as the Sustainability Report

Baxter International Inc. (NYSE:BAX), a global medtech leader, today published its newly renamed 2025 Sustainability Report, highlighting the company’s progress and refreshed approach to advancing a sustainable and responsible business model.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260622741106/en/

Baxter Publishes 2025 Sustainability Report Highlighting Refreshed Strategy, Ongoing Commitment to Drive Meaningful Impact

"As we shape Baxter’s next chapter, our focus remains clear: making a meaningful difference for patients, customers and communities while working to create long‑term value for all stakeholders," said Andrew Hider, president and chief executive officer. "The progress captured in this report is the result of the dedication of Baxter colleagues who bring our Mission to Save and Sustain Lives to life every day. Their commitment continues to drive Baxter forward and strengthen our ability to create lasting value for those we serve."

The report highlights Baxter’s progress across key priorities in 2025, including strengthening collaboration with healthcare partners to improve patient care, driving operational efficiency and environmental sustainability, and advancing a culture of safety and well-being for employees. The company and the Baxter Foundation also continued investing in communities worldwide, including more than $32 million in contributions through strategic partnerships, product donations and employee matching gifts. Building on this progress and more than 30 years of environmental reporting, the company has refined its sustainability strategy and governance approach.

Refreshed Sustainability Strategy and Governance

Aligned to Baxter Growth and Performance System (GPS), which was introduced in 2025, the company strengthened its approach to sustainability governance with the establishment of its first chief sustainability officer role and newly created sustainability team, enhancing coordination and accountability across the enterprise.

Informed by the company’s recent double materiality assessment, Baxter has refreshed both its sustainability strategy and reporting to reflect a more forward-looking approach to long-term value creation for its stakeholders. The company’s refined sustainability strategy centers on three core areas: Deliver Sustainable Healthcare, Advance Climate & Resiliency, and Champion People & Communities. The refreshed areas of focus led to a new set of targets designed to drive measurable progress, replacing the 2030 commitments previously established. New targets include:

Net-Zero greenhouse gas emissions (GHG) across Scope 1 and Scope 2 by 2050, aligned with a 1.5⁰ Celsius science-based target
100% renewable electricity by 2040
80% of supplier spend in priority categories with suppliers that have science-based targets by 2030
100,000 employee volunteer hours by 2031, along with a previously established goal to invest $275 million by 2030 in underserved communities

The sustainability strategy and goals continue to support the United Nations Sustainable Development Goals (SDG), with particular emphasis on advancing health and well‑being (SDG 3), water stewardship (SDG 6), responsible consumption (SDG 12), and climate action (SDG 13).

"When I joined Baxter as its first chief sustainability officer, I saw firsthand a culture grounded in care, collaboration and an unwavering commitment to patients," said Renae Kezar, chief sustainability officer. "Sustainability is essential to enabling resilient healthcare delivery. Our sustainability strategy is designed to help ensure safe, reliable care while addressing the challenges facing healthcare and communities globally."

Learn more and view the full report here.

About Baxter

At Baxter, we are everywhere healthcare happens – and everywhere it is going, with essential solutions in the hospital, physician’s office and other sites of care. For nearly a century, our customers have counted on us as a vital and trusted partner. And every day, millions of patients and healthcare providers rely on our unmatched portfolio of connected solutions, medical devices, and advanced injectable technologies. Approximately 37,500 Baxter team members live our enduring Mission: to Save and Sustain Lives. Together, we are redefining how care is delivered to make a greater impact today, tomorrow, and beyond. To learn more, visit www.baxter.com and follow us on X, LinkedIn and Facebook.

This release includes forward-looking statements concerning Baxter's sustainability strategy described in the release, including newly launched sustainability targets. The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: the company may be unable to successfully introduce or monetize new and existing products or services or keep pace with changing consumer preferences and needs or advances in technology; the company’s operating results and financial condition have fluctuated and may fluctuate in the future, which may constrain the company’s ability to achieve its financial and other goals; the company has experienced in the past and may in the future experience manufacturing, sterilization, supply, or distribution difficulties; the effects of climate change, including legal, regulatory, or market measures related to climate change and other sustainability topics, could adversely affect the company’s business, results of operations, financial condition, and cash flows; the company is subject to laws and regulations globally, and its failure to comply with rapidly changing and increasingly divergent expectations of regulators in different jurisdictions could adversely impact the company; and other risks identified in Baxter's most recent filing on Form 10-K and Form 10-Q and other SEC filings, all of which are available on Baxter's website. Baxter does not undertake to update its forward-looking statements.

Baxter is a registered trademark of Baxter International Inc. or its subsidiaries.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260622741106/en/

Media Contact

Natalie Matthews, (224) 948-5353

media@baxter.com

Investor Contact

Kevin Moran, (224) 507-3759

global_corp_investor_relations@baxter.com